A December 20, 2006 article by Kara Sissell from Chemical Week notes ACSH's report on BPA:
Alleged links between exposure to low doses of bisphenol A (BPA) and some diseases cannot be supported by the available data, says a report released last week by the American Council on Science and Health (ACSH; New York), which receives some funding from industry. A review of existing data concludes that animal studies showing a link between BPA and disease "cannot be validly extrapolated to the human situation," ACSH says.
"The available data do not establish that...exposure to these substances at low doses produces adverse health effects," ACSH says. "There is no compelling evidence that people are being put at risk by current levels of exposure to BPA or other substances alleged to be 'endocrine disruptors'."
ACSH also refutes conclusions from two human studies: one describing a correlation between BPA and ovarian dysfunction, and another showing a link between BPA and miscarriage. "In both studies, there is reason to suspect that the observed differences in BPA levels might be a result of hormonal differences between the groups of women, rather than the cause of them," the report says. "In fact, the scientists who conducted the ovarian dysfunction study suggested this is the likely explanation for their findings," it says.
